Association between Chlamydial Infection with Ectopic and Full-Term Pregnancies: A Case-Control Study
by
, , , ,
Valliammai Jayanthi Thirunavuk Arasoo
1,*,
Mariyammah Masalamani
1,
Amutha Ramadas
1
,
Nisha Angela Dominic
1,
Darien Daojuin Liew
1,
Robin Wai Jen Sia
1,
Anuradha Wanigaratne
1,
Keshawa Weerawarna
1,
William Lik Loong Wong
1 and
Ravichandran Jeganathan
2 1
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Selangor, Malaysia
2
Department of Obstetrics and Gynaecology, Hospital Sultanah Aminah Johor Bahru, Johor Bahru 81200, Johor, Malaysia
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2022, 7(10), 285; https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed7100285
Submission received: 1 September 2022
/
Revised: 1 October 2022
/
Accepted: 2 October 2022
/
Published: 6 October 2022
(This article belongs to the Special Issue Emerging Diseases/Viruses Prevention: Control, Surveillance, and One Health)
Abstract
:Ectopic pregnancies (EPs) are potentially fatal if not recognized early. Evidence of an association with chlamydial infection in South East Asia is lacking. This case-control study aims to (i) compare chlamydial infection in women with EP to women who delivered a full-term pregnancy, (ii) investigate classical factors associated with EP, and (iii) investigate rupture status in EP. Seventy-two women with a confirmed diagnosis of EP and sixty-nine who delivered a full-term pregnancy in a tertiary hospital in Malaysia were recruited from November 2019 to January 2022. Demographic and relevant clinical data and intraoperative findings were documented. Blood samples for testing IgG levels of chlamydia were obtained. Women with EP were more likely to have tested positive for chlamydia than those with a full-term delivery (34.7% vs. 13.0%, AOR = 4.18, 95% CI = 1.67–10.48, p = 0.002). The majority did not have the classic risk factors associated with EP. An amount of 52.8% presented with a ruptured EP, with 84.2% of ruptures occurring after six weeks of gestation. An amount of 44.2% had an estimated blood loss of more than 500 cc, with 20% losing more than 1500 cc of blood. The prevalence of prior chlamydial infection in women with EP is significant enough to necessitate a review of early pregnancy care.
1. Introduction
Ectopic pregnancy (EP) was the fourth leading cause of maternal mortality in Malaysia in the years 2019 and 2020 [1]. Common risk factors include infections, surgery, smoking, in vitro fertilization, previous EP, previous pelvic surgery, and intrauterine device use [2,3,4]. Although the exact pathogenesis of EP is unknown, it is hypothesized that impaired embryo tubal transportation and alterations in the tubal environment result in embryo retention within the fallopian tubes [2,3].
The tubal environment is governed by sex hormones, cytokines, growth factors, expression proteins, and the surveillance of immune cells. Infection-stimulated cytokines are involved in the development of EP. There is an increased interleukin-6 (IL-6) level and leukemia inhibitory factor (LIF) in the fallopian tubes of women with EP [3]. Epithelial shedding due to chronic salpingitis is thought to result in the exposure of the stromal surface in the fallopian tube, producing high levels of the LIF, facilitating the implantation of the arrested embryo [2]. Prior studies postulate that EP could be linked to chronic pelvic inflammation [2,5,6].
Chlamydia trachomatis (C. trachomatis) has been reported as the most common pathogen that leads to sexually transmitted infections (STIs) [3,7]. The World Health Organization estimates that in 2016, there were 376 million new infections, with one in four being STIs: chlamydia (127 million), gonorrhea (87 million), syphilis (6.3 million), and trichomoniasis (156 million). C. trachomatis is associated with pelvic inflammatory disease, infertility, and EP [8]. Other common bacterial infections include Neisseria gonorrhoea and Mycoplasma genitalium [3]. In healthy women, the expression of intrauterine integrins is associated with successful intrauterine implantation. However, a prior C. trachomatis infection results in increased integrin expression in the tubal epithelial cells, which likely promotes trophoblast attachment leading to EP [9].
A recent meta-analysis concluded that EP was more likely in pregnant women who tested positive than those who did not [6]. Although this meta-analysis categorized eight studies as Asian, only two studies were from South East Asia, namely, Thailand [10] and Vietnam [11], which reported relatively smaller sample sizes. Additionally, studies exploring the prevalence of chlamydia infection in Malaysia were targeted at specific populations such as the urban population [12], prostitutes [13], and those seen at the infertility clinic [14,15]. As there is a scarcity of regional data on the prevalence of C. trachomatis infection, presenting features, and intraoperative findings in patients with EP, this study could provide some insight.
Hence, we aimed (i) to compare the prevalence of prior chlamydial infection in women with EP and women who delivered from 37 weeks onwards, (ii) to assess the contribution of chlamydial infection and associated risk factors to EP, and (iii) to document the period of gestation when an EP is more likely to rupture.
2. Materials and Methods
2.1. Study Design
This was an unmatched case-control study conducted in Hospital Sultanah Aminah Johor Bahru, Malaysia, among adult women (>18 years) with a confirmed diagnosis of EP (case) or admitted for delivery from 37 weeks onwards (control). We obtained ethical approval from the Malaysian Research Ethics Committee (MREC) (NMMR: 18-3214-44797) and the Monash University Human Research Ethics Committee (MUHREC) (ID: 18558) prior to the commencement of the study.
2.2. Recruitment and Data Collection
Consenting patients aged 18 and above admitted for management of a confirmed diagnosis of EP were recruited with informed consent. Patients who were clinically stable either pre- or post-operative were recruited. Controls were those aged 18 and above admitted for delivery from 37 weeks onwards. Only those in the latent phase of labor or admitted for labor induction were recruited as controls. Patients above 18 who had impairments such as hearing impairment were excluded.
Demographic data that were collected included age, ethnicity, marital status and education level. Relevant clinical data recorded included the number of sexual partners, parity status, risk factors for EP, and clinical findings. These are tabulated in Table 1 and Table 2. Blood samples totaling 5 mL were obtained for testing IgG levels of chlamydia. Detection of chlamydia IgG was performed by an independent external lab using CHLG-chlamydia IgG (immunoblot), and a result, >1.00 was considered positive.
The study recruitment and primary data collection took place at Hospital Sultanah Aminah Johor Bahru, Malaysia, between November 2019 and January 2022. Although an average of two patients with EP were treated per week, data collection was paused during the COVID-19 pandemic due to the government’s implementation of the movement control order (MCO). At this center, the primary method of treatment employed for EP was the surgical approach (either laparoscopic or laparotomy). Patients who were clinically stable underwent the laparoscopic approach. However, if there were significant challenges intraoperatively or if the patient had significant hemoperitoneum, the approach was converted to laparotomy.
2.3. Sample Size Justification
The minimal sample size was estimated using OpenEPI [16] based on the difference in the proportion of outcome (EP) according to parity (1 vs. >3) as reported by Mpiima et al. [17] The authors reported the prevalence of ectopic pregnancy among those in parity of 1 (unexposed) to be 2.38% as opposed to those with parity >3 (exposed) which was 18.75%. A minimum sample size of 66 was required in each group to give the study 80% power at α = 0.05 (two-sided).
2.4. Statistical Analysis
Data collected were tabulated and analyzed using IBM® SPSS® Statistics Ver.26.0. Descriptive statistics such as frequencies, percentages, means, and standard deviations were used to describe the study participants’ characteristics. Associations between categorical variables and study groups were determined with Pearson’s chi-square or Fisher’s exact tests. Mean values of continuous variables were compared between the study groups using independent t-tests. Multivariable logistic regression (enter method) was used to determine the relationship between chlamydia infection and EP. Variables with a p value >0.25 in the bivariate analysis were adjusted for in the multivariate model. The model’s goodness-of-fit was determined using the Hosmer–Lemeshow test. The adjusted model was also assessed for multicollinearity and interactions between variables. Statistical significance was set at p < 0.05.
3. Results
Seventy-two patients with EP and sixty-nine women with a non-ectopic full-term pregnancy between 37 and 40 weeks of gestation were recruited for the study. The mean age of the study patients was 30.16 years (SD = 5.07 years). The majority of them were of Malay ethnicity (79.1%), were Muslim (80.1%), had at least a secondary level of education (97.2%), and were employed (66%). More than 80% of the patients and their partners were married for the first time and had only one partner. None of the demographic characteristics differed between the study groups (Table 1).
Nine study patients had pelvic surgery performed within the past year. Three patients underwent lower segment caesarean section (LSCS); others underwent one of the following surgeries: appendectomy, dilatation and curettage (D and C), endometrial polypectomy laparoscopic myomectomy, laparoscopic salpingectomy, and salpingectomy. Although only eight patients had a smoking history, those with EP had been smoking for significantly longer than controls (14.60 ± 6.02 years vs. 2.97 ± 4.36 years, p = 0.028). The remaining clinical characteristics did not differ between study groups (Table 2).
Almost a quarter of all pregnancies were also infected with chlamydia, as observed with the presence of chlamydia IgG antibodies (Table 3). Chlamydia infection was more prevalent in EP patients compared to non-ectopic pregnancy patients (34.7% vs. 13.0%). After adjusting for potential confounding factors, the odds for chlamydia infection were higher than four-fold in EP patients than in the control group (aOR = 4.18, 95% CI = 1.67–10.48, p = 0.002).
In subsequent analysis, we explored the association between EP-related characteristics and chlamydia IgG antibodies (Table 4). Per vaginal bleeding was twice more common in chlamydia-infected EP cases compared to EP cases negative for the infection (50.0% vs. 24.0%, p = 0.033). The choice of management options also differed between those with and without infection (p = 0.002). Laparotomy salpingectomy was the most common management choice among all patients (47.9%), especially those infected with chlamydia (60.0%). However, laparoscopic salpingectomy was more common among those without the infection (56.5%). Other variables were not found to be associated with chlamydia infection.
No association between EP rupture status and gestation period was found (Table 5).
4. Discussion
In our study, 34.7% of women with EP and 13.0% who delivered full term were IgG positive for chlamydia. Very few studies in South East Asia report the prevalence of chlamydia infection in women with EP. An analysis of 177 women with EP in Vietnam reported that only 24.9% tested IgG positive for chlamydia [11]. In a small study of 32 Thai women with EP, although 34.38% had chlamydia DNA in the fallopian tube, only 21.88% had serum-specific IgG for chlamydia. However, no strong independent association between EP risk and chlamydia antibodies was demonstrated [10]. Detecting chlamydial antibodies decreases with time since the initial infection. However, a higher proportion of women with more than one diagnosed chlamydial infection have detectable antibody levels beyond six months [18]. Based on these two studies [10,18], it can be postulated that our sample of women with EP had chlamydial infections much earlier and tested negative for the antibodies. It could also suggest that the women in our study who tested positive were possibly in the first six months of initial infection or had more than one episode of infection.
Although we reported a higher prevalence of chlamydia antibodies in our participants compared to others from the region, a study conducted in Uganda reported double our figures, where 60% of women with EP and 26.32% of those with an intrauterine pregnancy had chlamydia antibodies [17]. This may be attributed to differences in the prevalence of chlamydia in the general population. Malaysia currently does not have data on the prevalence of chlamydia infection in the general population.
Intraoperatively, only 16.0% of those who were IgG positive and 4.4% who were negative had peri tubal adhesions on at least one side. A developed mathematical model estimated that 10% of untreated chlamydial infections could result in PID [19]. Our findings were not that far off from the estimate of the mathematical model. Peri tubal adhesions in our study were not classified according to any validated scoring system. It should be noted and included in patient counselling that a higher revised American Fertility Society score is associated with a higher occurrence of repeat EPs [20].
Traditional risk factors associated with EP include a history of PID, smoking, history of pelvic surgery, and use of copper IUCD. In our study, none of these factors were significantly associated with EP. Similar findings were reported by another study [21]. Hence, a meta-analysis should be conducted to understand the usefulness of traditional risk factors in current times.
Although there were twenty-five women with EP and nine women with a full-term pregnancy who tested positive, they largely did not report symptoms to suggest PID. This finding is not unique to our study, as other studies have also reported that chlamydia seropositivity was more common than a documented or reported history of infection [22,23].
Other microorganisms such as Mycoplasma genitalium [24] and Neisseria gonorrhoea [25] also cause PID that can damage the tubes resulting in EP. Although we did not test for these microorganisms, it is known that C. trachomatis infection occurs more frequently than M. genitalium or N. gonorrhoea infection.
A prospective cohort study of 5704 Dutch women (29.5% chlamydia positive) reported an EP incidence rate of 0.8 per 1000 person-years (0.4 to 1.5) in those who had prior chlamydia infection and 0.6 per 1000 person-years (0.4 to 0.6) for women who were chlamydia negative [26]. The incidence of EP in both groups was approximately the same. This, combined with our findings that 65.5% of women with EP tested negative for chlamydia and had no association with traditional risk factors, leads to the question of whether another factor facilitates blastocyst implantation in the fallopian tube before it reaches the uterine cavity. There is also the possibility of undetected microbes colonizing the tubes or even dysbiosis.
Our study aims included documenting the period of gestation (POG) that tubal EP ruptured. Ruptures were seen in 38 (52.8%) women with EP. Although there was no statistically significant specific POG that rupture occurred in our study, 84.2% of EPs ruptured after a six-week POG. Patient factors that led to a delay in seeking early pregnancy care were not explored in our study. This suggests that early self-tests and seeking pregnancy care earlier should be encouraged. A study of 48 women with ruptured EP and 51 women with unruptured EP, reported that the POG for a ruptured EP was 8.0 ± 0.9 weeks and 7.3 ± 1.0 weeks for an unruptured EP. However, these values were statistically insignificant [27]. In another study of 144 women with ruptured EP and 79 women with unruptured EP, a rupture occurred at 53.9 ± 4.7 days (7.7 ± 0.7 weeks). This finding was reported as borderline significant [21]. The plausible reason we failed to document any significant POG for tubal rupture is that the POGs recorded in our study were largely calculated based on the self-reported first day of the last menstrual period, thus, making them less objective.
Approximately 44% (n = 31) of the EPs had significant blood loss of more than 500 mls, with approximately half of them having a massive hemorrhage, likely requiring blood transfusion. Approximately 45% (n = 14) of this group were IgG positive for chlamydia, while the remainder were negative, which was not statistically significant. However, this degree of hemorrhage remains a contributing factor to maternal morbidity and mortality, as reflected by our recent statistics [1].
Our study is one of the very few studies from South East Asia that documented the presence of chlamydial infection in women with EP compared to women who delivered full term. We found an alarmingly high presence of prior chlamydial infection in women with EP and an unexpected presence of prior infection in women who delivered full term.
A limitation of this study is that we tested only for chlamydial infection and not for other microorganisms such as M. genitalium and N. gonorrhoea. Another limitation is that the test kit did not discern the type of chlamydia infection. However, Chlamydia psitacci infection is uncommon in our population.
5. Conclusions
EP continues to be a significant cause of maternal mortality in Malaysia. Early diagnosis and prompt management are crucial as ruptures tend to occur after a six-week POG. Although chlamydial infection is significantly associated with EP, almost two-thirds of the women with EP in our study did not have the infection. Relying on traditional textbook risk factors to formulate a diagnosis is not helpful as our study reported no significant risk factors. A meta-analysis could be conducted to understand the usefulness of traditional risk factors in current times. The authors believe that further research should explore the role of female reproductive tract dysbiosis and the role of passive smoking as causative factors of EP. Research into the duration from which infection occurs until the time EP results could explain why some women with prior chlamydial infection delivered a full-term pregnancy.
Author Contributions
Conceptualization, V.J.T.A., D.D.L., R.W.J.S., A.W. and R.J.; Data curation, M.M. and A.R.; Formal analysis, A.R.; Funding acquisition, V.J.T.A.; Investigation, M.M., K.W. and W.L.L.W.; Methodology, V.J.T.A., D.D.L., R.W.J.S. and A.W.; Project administration, V.J.T.A. and N.A.D.; Resources, V.J.T.A. and N.A.D.; Software, A.R.; Supervision, V.J.T.A., N.A.D. and R.J.; Validation, A.R.; Writing—original draft, V.J.T.A., M.M., A.R., D.D.L., R.W.J.S., A.W., K.W. and W.L.L.W.; Writing—review and editing, V.J.T.A., M.M., A.R., N.A.D., D.D.L., R.W.J.S., A.W., K.W., W.L.L.W. and R.J. All authors have read and agreed to the published version of the manuscript.
Funding
This study was funded by the Tropical Medicine and Biology Platform Seed grant (TMB-2022-CR3185140918) and the Monash University Malaysia Internal Seed grant (SCH SEED/2020/002).
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Malaysian Research Ethics Committee (MREC) (NMMR: 18-3214-44797) and the Monash University Human Research Ethics Committee (MUHREC) (ID: 18558).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The data presented in this study are available on request from the corresponding author. The data are not publicly available due to informed consent conditions.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Department of Statistics, Malaysia. Population and Demography; Department of Statistics: Putrajaya, Malaysia, 2021.
- Shaw, J.L.V.; Dey, S.K.; Critchley, H.O.D.; Horne, A.W. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum. Reprod. Update 2010, 16, 432–444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Refaat, B.; Ashshi, A.M.; Batwa, S.A.; Ahmad, J.; Idris, S.; Kutbi, S.Y.; Malibary, F.A.; Kamfar, F.F. The prevalence of Chlamydia trachomatis and Mycoplasma genitalium tubal infections and their effects on the expression of IL-6 and leukaemia inhibitory factor in Fallopian tubes with and without an ectopic pregnancy. Innate Immun. 2016, 22, 534–545. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, C.; Zhao, W.-H.; Zhu, Q.; Cao, S.J.; Ping, H.; Xi, X.; Qin, G.-J.; Yan, M.-Y.; Zhang, D.; Qiu, J.; et al. Risk factors for ectopic pregnancy: A multi-center case-control study. BMC Pregnancy Childbirth 2015, 15, 187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shaw, J.L.V.; Wills, G.S.; Lee, K.-F.; Horner, P.J.; McClure, M.O.; Abrahams, V.M.; Wheelhouse, N.; Jabbour, H.N.; Critchley, H.O.D.; Entrican, G.; et al. Chlamydia trachomatis Infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancy. Am. J. Pathol. 2011, 178, 253–260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xia, Q.; Wang, T.; Xian, J.; Song, J.; Qiao, Y.; Mu, Z.; Liu, H.; Sun, Z. Relation of Chlamydia trachomatis infections to ectopic pregnancy: A meta-analysis and systematic review. Medicine 2020, 99, e18489. [Google Scholar] [CrossRef] [PubMed]
- Keegan, M.B.; Diedrich, J.T.; Peipert, J.F. Chlamydia trachomatis infection: Screening and management. J. Clin. Outcomes Manag. 2014, 21, 30–38. [Google Scholar] [PubMed]
- Rowley, J.; Vander Hoorn, S.; Korenromp, E.; Low, N.; Unemo, M.; Abu-Raddad, L.J.; Chico, R.M.; Smolak, A.; Newman, L.; Gottlieb, S.; et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull. World Health Organ. 2019, 97, 548–562. [Google Scholar] [CrossRef]
- Ahmad, S.F.; Brown, J.K.; Campbell, L.L.; Koscielniak, M.; Oliver, C.; Wheelhouse, N.; Entrican, G.; McFee, S.; Wills, G.S.; McClure, M.O.; et al. Pelvic chlamydial infection predisposes to ectopic pregnancy by upregulating integrin β1 to promote embryo-tubal attachment. EBioMedicine 2018, 29, 159–165. [Google Scholar] [CrossRef] [Green Version]
- Pientong, C.; Ekalaksananan, T.; Wonglikitpanya, N.; Swadpanich, U.; Kongyingyoes, B.; Kleebkaow, P. Chlamydia trachomatis infections and the risk of ectopic pregnancy in Khon Kaen women. J. Obstet. Gynaecol. Res. 2009, 35, 775–781. [Google Scholar] [CrossRef]
- Hornung, S.; Thuong, B.C.; Gyger, J.; Kebbi-Beghdadi, C.; Vasilevsky, S.; Greub, G.; Baud, D. Role of Chlamydia trachomatis and emerging Chlamydia-related bacteria in ectopic pregnancy in Vietnam. Epidemiol. Infect. 2015, 143, 2635–2638. [Google Scholar] [CrossRef]
- Ngeow, Y.F.; Rachagan, S.P.; Ramachandran, S. Prevalence of chlamydial antibody in Malaysians. J. Clin. Pathol. 1990, 43, 400–402. [Google Scholar] [CrossRef]
- Ramachandran, S.; Ngeow, Y.F. The prevalence of sexually transmitted diseases among prostitutes in Malaysia. Genitourin Med. 1990, 66, 334–336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yeow, T.C.; Wong, W.F.; Sabet, N.S.; Sulaiman, S.; Shahhosseini, F.; Tan, G.M.Y.; Movahed, F.; Looi, C.Y.; Shankar, E.M.; Gupta, R.; et al. Prevalence of plasmid-bearing and plasmid-free Chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia. BMC Microbiol. 2016, 16, 45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Suvra, B.; Zainul, R.; Zalina, I.; Anita, S. Prevalence rates of Chlamydia Trachomatis and other sexually transmitted organisms in infertile couples attending a tertiary medical centre in Malaysia. IIUM Med. J. Malays. 2020, 19, 61–74. [Google Scholar] [CrossRef]
- Sullivan, K.M.; Dean, A.; Minn Minn, S.O.E. OpenEpi: A web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009, 124, 471–474. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mpiima, D.P.; Wasswa Salongo, G.; Lugobe, H.; Ssemujju, A.; Mumbere Mulisya, O.; Masinda, A.; Twizerimana, H.; Ngonzi, J. Association between prior Chlamydia trachomatis infection and ectopic pregnancy at a tertiary care hospital in South Western Uganda. Obstet. Gynecol. Int. 2018, 2018, 4827353. [Google Scholar] [CrossRef] [Green Version]
- Horner, P.J.; Wills, G.S.; Reynolds, R.; Johnson, A.M.; Muir, D.A.; Winston, A.; Broadbent, A.J.; Parker, D.; McClure, M.O. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: A cross-sectional study. Sex Transm. Infect. 2013, 89, 398–403. [Google Scholar] [CrossRef]
- Herzog, S.A.; Althaus, C.L.; Heijne, J.C.M.; Oakeshott, P.; Kerry, S.; Hay, P.; Low, N. Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: A mathematical modelling study. BMC Infect. Dis. 2012, 12, 187. [Google Scholar] [CrossRef] [Green Version]
- Kuroda, K.; Takeuchi, H.; Kitade, M.; Kikuchi, I.; Shimanuki, H.; Kumakiri, J.; Kobayashi, Y.; Kuroda, M.; Takeda, S. Assessment of tubal disorder as a risk factor for repeat ectopic pregnancy after laparoscopic surgery for tubal pregnancy. J. Obstet. Gynaecol. Res. 2009, 35, 520–524. [Google Scholar] [CrossRef]
- Sindos, M.; Togia, A.; Sergentanis, T.N.; Kabagiannis, A.; Malamas, F.; Farfaras, A.; Sergentanis, I.N.; Bassiotou, V.; Antoniou, S. Ruptured ectopic pregnancy: Risk factors for a life-threatening condition. Arch. Gynecol. Obstet. 2008, 279, 621. [Google Scholar] [CrossRef]
- Gorwitz, R.J.; Wiesenfeld, H.C.; Chen, P.L.; Hammond, K.R.; Sereday, K.A.; Haggerty, C.L.; Johnson, R.E.; Papp, J.R.; Kissin, D.M.; Henning, T.C.; et al. Population-attributable fraction of tubal factor infertility associated with chlamydia. Am. J. Obstet. Gynecol. 2017, 217, 336.e1–336.e16. [Google Scholar] [CrossRef] [PubMed]
- Verweij, S.; Kebbi-Beghdadi, C.; Land, J.; Ouburg, S.; Morre, S.A.; Greub, G. Chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology. Microbes Infect. 2015, 17, 745–748. [Google Scholar] [CrossRef] [PubMed]
- Bjartling, C.; Osser, S.; Persson, K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am. J. Obstet. Gynecol. 2012, 206, 476.e1–476.e8. [Google Scholar] [CrossRef] [PubMed]
- Burnett, A.M.; Anderson, C.P.; Zwank, M.D. Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Am. J. Emerg. Med. 2012, 30, 1114–1117. [Google Scholar] [CrossRef]
- Hoenderboom, B.M.; van Benthem, B.H.B.; van Bergen, J.E.A.M.; Dukers-Muijrers, N.H.; Götz, H.M.; Hoebe, C.J.; Hogewoning, A.A.; Land, J.A.; van der Sande, M.A.B.; Morré, S.A.; et al. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm. Infect. 2019, 95, 300–306. [Google Scholar]
- Roussos, D.; Panidis, D.; Matalliotakis, I.; Mavromatidis, G.; Neonaki, M.; Mamopoulos, M.; Koumantakis, E. Factors that may predispose to rupture of tubal ectopic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 89, 15–17. [Google Scholar] [CrossRef]
Table 1.
Demographic characteristics of the study patients (N = 141).
| All Patients | Ectopic Pregnancy (Case) | Non-Ectopic Full-Term Pregnancy (Control) | p Value | ||
|---|---|---|---|---|---|
| (N = 141) | (n = 72) | (n = 69) | |||
| Age (years) | Mean (SD) | 30.16 (5.07) | 30.44 (4.68) | 29.87 (5.47) | 0.503 |
| Ethnicity | Malay | 112 (79.2) | 59 (81.9) | 53 (76.8) | 0.718 |
| Chinese | 10 (7.1) | 4 (5.6) | 6 (8.7) | ||
| Indian | 18 (12.8) | 9 (12.5) | 9 (13.0) | ||
| East Malaysian Native | 1 (0.7) | 0 (0.0) | 1 (1.4) | ||
| Education | Primary | 4 (2.8) | 2 (2.8) | 2 (2.9) | 0.512 |
| Secondary | 72 (51.1) | 40 (55.6) | 32 (46.4) | ||
| Tertiary | 65 (46.1) | 30 (41.7) | 35 (50.7) | ||
| Employment | Yes | 93 (66.0) | 49 (68.1) | 44 (63.8) | 0.591 |
| No | 48 (34.0) | 23 (31.9) | 25 (36.2) | ||
| Patient’s marital status | Single | 4 (2.8) | 2 (2.8) | 2 (2.9) | |
| First marriage | 118 (83.7) | 60 (83.3) | 58 (84.1) | ||
| Second marriage or more | 19 (13.5) | 10 (13.9) | 9 (13.0) | ||
| Partner’s marital status | Single | 5 (3.5) | 2 (2.8) | 3 (4.3) | 0.816 |
| First marriage | 118 (83.7) | 60 (83.3) | 58 (84.1) | ||
| Second marriage or more | 18 (12.8) | 10 (13.9) | 8 (11.6) | ||
| Number of partners | 0 | 1 (0.7) | 1 (1.4) | 0 (0.0) | 0.155 |
| 1 | 114 (82.0) | 60 (85.7) | 54 (78.3) | ||
| 2 | 23 (16.5) | 8 (11.4) | 15 (21.7) | ||
| 3 | 1 (0.7) | 1 (1.4) | 0 (0.0) |
Table 2.
Clinical characteristics of the study patients (N = 141).
| All Patients | Ectopic Pregnancy (Case) | Non-Ectopic Full-Term Pregnancy (Control) | p Value | ||
|---|---|---|---|---|---|
| (N = 141) | (n = 72) | (n = 69) | |||
| Gravida | 1 | 49 (34.8) | 30 (41.7) | 19 (27.5) | 0.193 |
| 2–3 | 58 (41.1) | 25 (34.7) | 33 (47.8) | ||
| 4–5 | 23 (16.3) | 13 (18.1) | 10 (14.5) | ||
| More than 5 | 11 (7.8) | 4 (5.6) | 7 (10.1) | ||
| Parity | 0 | 58 (41.1) | 36 (50.0) | 22 (31.9) | 0.088 |
| 1–2 | 64 (45.4) | 28 (38.9) | 36 (52.2) | ||
| 3–4 | 17 (12.1) | 8 (11.1) | 9 (13.0) | ||
| More than 4 | 2 (1.4) | 0 (0.0) | 2 (2.9) | ||
| History of EP | Yes | 5 (3.5) | 4 (5.6) | 1 (1.4) | 0.367 |
| No | 136 (96.5) | 68 (94.4) | 68 (98.6) | ||
| History of PID | Yes | 5 (3.5) | 4 (5.6) | 1 (1.4) | 0.367 |
| No | 136 (96.5) | 68 (94.4) | 68 (98.6) | ||
| History of pelvic surgery | Yes | 9 (6.4) | 4 (5.8) | 5 (6.9) | 1.000 |
| No | 132 (93.6) | 65 (94.2) | 67 (93.1) | ||
| History of smoking | Yes | 8 (5.7) | 5 (6.9) | 3 (4.3) | 0.719 |
| No | 133 (94.3) | 67 (93.1) | 66 (95.7) | ||
| Duration of smoking (years) | Mean (SD) | 10.23 (7.90) | 14.60 (6.02) | 2.97 (4.36) | 0.028 * |
| Prior use of copper IUD | Yes | 3 (2.1) | 1 (1.4) | 2 (2.9) | 0.614 |
| No | 138 (97.9) | 71 (98.6) | 67 (97.1) | ||
| Purulent per vaginal discharge | Yes | 13 (9.2) | 9 (12.5) | 4 (5.8) | 0.169 |
| No | 128 (90.8) | 63 (87.5) | 65 (94.2) | ||
| Abdominal pain with fever | Yes | 6 (4.3) | 4 (5.6) | 2 (2.9) | 0.681 |
| No | 135 (95.7) | 68 (94.4) | 67 (97.1) | ||
| Pelvic pain with fever | Yes | 1 (0.7) | 1 (1.4) | 0 (0.0) | 1.000 |
| No | 140 (99.3) | 71 (98.6) | 69 (100.0) |
EP = ectopic pregnancy, PID = pelvic inflammatory disease. * Significant at p < 0.05.
Table 3.
Association between chlamydia IgG antibodies and ectopic pregnancies (N = 141).
| All Patients | Ectopic Pregnancy (Case) | Non-Ectopic Full-Term Pregnancy (Control) | ||
|---|---|---|---|---|
| (N = 141) | (n = 72) | (n = 69) | ||
| Chlamydia IgG antibodies | Positive | 34 (24.1) | 25 (34.7) | 9 (13.0) |
| Negative | 107 (75.9) | 47 (65.3) | 60 (87.0) | |
| OR a (95% CI) | 3.55 (1.51–8.31) | 1.000 | ||
| p value | 0.004 * | |||
| aOR b (95% CI) | 4.18 (1.67–10.48) | 1.000 | ||
| p value | 0.002 * |
a Unadjusted logistic regression model; b Adjusted for number of partners, gravidity, and purulent per vaginal discharge. Model fulfilled Hosmer–Lemeshow test (p = 0.211), multicollinearity, and interaction assumptions. * Significant at p < 0.05.
Table 4.
Association between ectopic pregnancy-related characteristics and chlamydia IgG antibodies (n = 72).
Table 4.
Association between ectopic pregnancy-related characteristics and chlamydia IgG antibodies (n = 72).
| All EP Patients | Chlamydia IgG Antibodies | p Value | |||
|---|---|---|---|---|---|
| Positive | Negative | ||||
| (N = 72) | (n = 25) | (n = 47) | |||
| History of EP | Yes | 4 (5.6) | 1 (4.0) | 3 (6.4) | 1.000 |
| No | 68 (94.4) | 24 (96.0) | 44 (93.6) | ||
| History of PID | Yes | 4 (5.6) | 1 (4.0) | 3 (6.4) | 1.000 |
| No | 68 (94.4) | 24 (96.0) | 44 (93.6) | ||
| History of pelvic surgery | Yes | 5 (6.9) | 0 (0.0) | 5 (10.6) | 0.156 |
| No | 67 (93.1) | 25 (100.0) | 42 (89.4) | ||
| History of smoking | Yes | 5 (6.9) | 1 (4.0) | 4 (8.5) | 0.652 |
| No | 67 (93.1) | 24 (96.0) | 43 (91.5) | ||
| Number of partners | 0 | 1 (2.9) | 0 (0.0) | 1 (0.7) | 0.071 |
| 1 | 25 (73.5) | 91 (85.0) | 116 (82.3) | ||
| 2 | 7 (20.6) | 16 (15.0) | 23 (16.3) | ||
| 3 | 1 (2.9) | 0 (0.0) | 1 (0.7) | ||
| Prior use of copper IUD | Yes | 1 (98.6) | 0 (0.0) | 1 (2.1) | 1.000 |
| No | 71 (1.4) | 25 (100.0) | 46 (97.9) | ||
| Period of gestation (weeks) | Unsure/<5 | 6 (8.5) | 2 98.0) | 4 (8.7) | 0.714 |
| 5–5+6 | 4 (5.6) | 0 (0.0) | 4 (8.7) | ||
| 6–6+6 | 19 (26.8) | 9 (36.0) | 10 (21.7) | ||
| 7–7+6 | 11 (15.5) | 3 (12.0) | 8 (17.4) | ||
| 8–8+6 | 23 (32.4) | 7 (28.0) | 16 (34.8) | ||
| ≥9 | 8 (11.3) | 4 (16.0) | 4 (8.7) | ||
| Purulent per vaginal discharge | Yes | 9 (12.5) | 4 (16.0) | 5 (10.6) | 0.710 |
| No | 63 (84.0) | 21 (84.0) | 42 (89.4) | ||
| Abdominal pain with fever | Yes | 4 (5.6) | 1 (4.0) | 3 (6.4) | 1.000 |
| No | 68 (94.4) | 24 (96.0) | 44 (93.6) | ||
| Pelvic pain with fever | Yes | 1 (1.4) | 1 (4.0) | 0 (0.0) | 0.347 |
| No | 71 (98.6) | 24 (96.0) | 47 (100.0) | ||
| Ectopic status | Not ruptured | 34 (47.2) | 9 (36.0) | 25 (53.2) | 0.164 |
| Ruptured | 38 (52.8) | 16 (64.0) | 22 (46.8) | ||
| Per vaginal bleeding a | Yes | 42 (59.2) | 23 (50.0) | 6 (24.0) | 0.033 * |
| No | 29 (40.8) | 23 (50.0) | 19 (76.0) | ||
| Abdominal pain a | Yes | 60 (84.5) | 20 (80.0) | 40 (87.0) | 0.501 |
| No | 11 (15.5) | 5 (20.0) | 6 (13.0) | ||
| Management options a | Laparoscopy salpingostomy | 2 (2.8) | 1 (4.0) | 1 (2.2) | 0.002 * |
| Laparoscopy salpingectomy | 31 (43.7) | 5 (20.0) | 26 (56.5) | ||
| Laparotomy salpingostomy | 2 (2.8) | 2 (8.0) | 0 (0.0) | ||
| Laparotomy salpingectomy | 34 (47.9) | 15 (60.0) | 19 (41.3) | ||
| Laparotomy cornual resection | 2 (2.8) | 2 (8.0) | 0 (0.0) | ||
| Uterus b | Uniformly enlarged | 23 (32.9) | 5 (20.0) | 18 (40.0) | 0.106 |
| Fibroids | 1 (1.4) | 1 (4.0) | 0 (0.0) | ||
| Normal | 46 (65.7) | 19 (76.0) | 27 (60.0) | ||
| Peritubal adhesions at least one side b | Yes | 6 (8.6) | 4 (16.0) | 2 (4.4) | 0.177 |
| No | 64 (91.4) | 21 (84.0) | 43 (95.6) | ||
| Peritubal adhesions at both sides b | Yes | 2 (2.9) | 2 (8.0) | 0 (0.0) | 0.124 |
| No | 68 (97.1) | 23 (92.0) | 45 (100.0) | ||
| Blood loss (ml) b | <500 | 39 (55.7) | 11 (44.0) | 28 (62.2 | 0.457 |
| 500–999 | 12 (17.1) | 5 (20.0) | 7 (15.6) | ||
| 1000–1499 | 5 (7.1) | 2 (8.0) | 3 (6.7) | ||
| ≥1500 | 14 (20.0) | 7 (28.0) | 7 (15.6) | ||
an = 71; b n = 70. * Significant at p < 0.05.
Table 5.
Association between gestation period (weeks) and rupture status in ectopic pregnancies.
| Period of Gestation (weeks) | All EP Patients | Rupture Status | p Value | |
|---|---|---|---|---|
| Ruptured | Not Ruptured | |||
| (N = 71) | (n = 38) | (n = 33) | ||
| <5/unsure | 6 (8.5) | 4 (10.5) | 2 (6.1) | 0.517 |
| 5–5+6 | 4 (5.6) | 2 (5.3) | 2 (6.1) | |
| 6–6+6 | 19 (26.8) | 13 (34.2) | 6 (18.2) | |
| 7–7+6 | 11 (15.5) | 4 (10.5) | 7 (21.2) | |
| 8–8+6 | 23 (32.4) | 12 (31.6) | 11 (33.3) | |
| ≥9 | 8 (11.3) | 3 (7.9) | 5 (15.2) | |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Thirunavuk Arasoo, V.J.; Masalamani, M.; Ramadas, A.; Dominic, N.A.; Liew, D.D.; Sia, R.W.J.; Wanigaratne, A.; Weerawarna, K.; Wong, W.L.L.; Jeganathan, R. Association between Chlamydial Infection with Ectopic and Full-Term Pregnancies: A Case-Control Study. Trop. Med. Infect. Dis. 2022, 7, 285. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed7100285
AMA Style
Thirunavuk Arasoo VJ, Masalamani M, Ramadas A, Dominic NA, Liew DD, Sia RWJ, Wanigaratne A, Weerawarna K, Wong WLL, Jeganathan R. Association between Chlamydial Infection with Ectopic and Full-Term Pregnancies: A Case-Control Study. Tropical Medicine and Infectious Disease. 2022; 7(10):285. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed7100285
Chicago/Turabian StyleThirunavuk Arasoo, Valliammai Jayanthi, Mariyammah Masalamani, Amutha Ramadas, Nisha Angela Dominic, Darien Daojuin Liew, Robin Wai Jen Sia, Anuradha Wanigaratne, Keshawa Weerawarna, William Lik Loong Wong, and Ravichandran Jeganathan. 2022. "Association between Chlamydial Infection with Ectopic and Full-Term Pregnancies: A Case-Control Study" Tropical Medicine and Infectious Disease 7, no. 10: 285. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed7100285
